研究紹介
Study

研究グループ

JCOG(日本臨床腫瘍研究グループ)やJROSG(日本放射線腫瘍学研究グループ)、NRG oncologyなど、国内外のさまざまな研究グループや臨床試験に参加しています。

近年の主な講演・発表・論文

江原威

対症療法に放射線治療の活用を!=骨転移だけじゃない対症的放射線治療=.第39回群馬緩和医療研究会,前橋,2019

水野将人、村上晋也、高木正人、榎本裕美、丸山靖、池田郁夫、戸成綾子、江原威

AIを組み込んだディープラーニング技術を用いたCT画像による放射線治療計画の試み.日本放射線腫瘍学会第32回学術大会,名古屋,2019

江原威、他

局所進行肺癌に対するカルボプラチン/nab-パクリタキセルの化学放射線療法の第I相試験.日本放射線腫瘍学会第31回学術大会,京都,2018

Ebara T, et al.

Radiation and concurrent superselective intra-arterial cisplatin for maxillary sinus cancer. ESTRO36, Vienna, 2017

江原威,他

表在食道癌(T1bN0M0)に対する放射線治療.第54回日本癌治療学会学術集会,横浜,2016

Ebara T, et al.

Definitive radiation therapy for superficial esophageal cancer (T1bN0M0). 日本放射線腫瘍学会第29回学術大会,京都,2016

戸成綾子

がん患者の相談者になる=放射線治療編,平成27年度がん看護研修会公開講演会,東京,2015

戸成綾子、他

当乳房温存術後照射時の周辺臓器への影響<甲状腺と心臓について> 日本放射線腫瘍学会第26回学術大会 青森,2014

Ebara T, Ando K, Eishima J, Suzuki M, Kawakami T, Horikoshi H, Tamaki Y

Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma. Jpn J Radiol 37(6):494-499, 2019.

Saitoh JI, Shirai K, Mizukami T, Abe T, Ebara T, Ohno T, Minato K, Saito R, Yamada M, Nakano T

Hypofractionated carbon-ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study. Cancer Med 8(15):6644-6650, 2019.

Akamatsu H, Nakamura K, Ebara T, Inaba K, Itasaka S, Jingu K, Kosaka Y, Murai T, Nagata K, Soejima T, Takahashi S, Toyoda T, Toyoshima S, Nemoto K, Akimoto T

Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey. J Radiat Res 60(4):509-516, 2019.

Sawaki M, Miyamoto T, Fujisawa T, Itoh Y, Ebara T, Tachibana H, Kodaira T, Kikumori T, Yanagita Y, Iwata H

Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence. Ann Surg Oncol 26(8):2428-2434, 2019.

Kaira K, Ono A, Kamide Y, Sunaga N, Koga Y, Saitoh JI, Shirai K, Ebara T, Hisada T, Ishizuka T

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non-small-cell lung cancer. J Radiat Res 60(2):228-233, 2019.

Eguchi K, Suzuki M, Ida S, Mori K, Imai H, Kudo S, Ando K, Higuchi K, Ebara T

Association Between Laryngopharyngeal Reflux and Radiation-induced Mucositis in Head and Neck Cancer. Anticancer Res 38(1):477-480, 2018.

Kimura T, Nagata Y, Harada H, Hayashi S, Matsuo Y, Takanaka T, Kokubo M, Takayama K, Onishi H, Hirakawa K, Shioyama Y, Ebara T

Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). Int J Clin Oncol 22(5):849-856, 2017.

Shirai K, Abe T, Saitoh JI, Mizukami T, Irie D, Takakusagi Y, Shiba S, Okano N, Ebara T, Ohno T, Nakano T

Maximum standardized uptake value on FDG-PET predicts survival in stage I non-small cell lung cancer following carbon ion radiotherapy. Oncol Lett 13(6):4420-4426, 2017.

Kaira K, Tomizawa Y, Imai H, Sakurai R, Matsuura M, Yoshii A, Ochiai M, Kotake M, Ebara T, Saitoh JI, Sunaga N, Minato K, Saito R, Hisada T

Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer. Cancer Chemother Pharmacol 79(1):165-171, 2017.

Abe T, Shirai K, Saitoh J, Ebara T, Shimada H, Tashiro M, Okano N, Ohno T, Nakano T

Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer. Acta Oncol 55(2):163-6, 2016.

Abe T, Tamaki T, Makino S, Ebara T, Hirai R, Miyaura K, Kumazaki Y, Ohno T, Shikama N, Nakano T, Kato S

Assessing cumulative dose distributions in combined radiotherapy for cervical cancer using deformable image registration with pre-imaging preparations. Radiat Oncol 20;9(1):293, 2014.

Ebara T, Shimada H, Kawamura H, Shirai K, Saito J, Kawashima M, Tashiro M, Ohno T, Kanai T, Nakano T

Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer. Anticancer Res 34(9):5099-5104, 2014.

Tonari A, Itaya N, Honda K, Sohara E, Kurai D, Okagawa T, Takayama M

Effectiveness if isotope therapy in addition to external beam irradiation therapy for pain control due to bone metastases -case report-. J Kyorin Med Soc 45(3):79-82, 2014.

近年の主な業績

  1. Miyasaka Y, Komatsu S, Abe T, Kubo N, Okano N, Shibuya K, Shirai K, Kawamura H, Saitoh J, Ebara T, Ohno T: Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. Cancers 6;13(2):176, 2021.
  2. Ebara T, Ando K, Eishima J, Suzuki M, Kawakami T, Horikoshi H, Tamaki Y: Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma. Jpn J Radiol 37(6):494-499, 2019.
  3. Abe T, Shirai K, Saitoh J, Ebara T, Shimada H, Tashiro M, Okano N, Ohno T, Nakano T: Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer. Acta Oncol 55(2):163-6, 2016.
  4. Ebara T, Shimada H, Kawamura H, Shirai K, Saito J, Kawashima M, Tashiro M, Ohno T, Kanai T, Nakano T: Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer. Anticancer Res 34(9):5099-5104, 2014.
  5. Tonari A, Itaya N, Honda K, Sohara E, Kurai D, Okagawa T, Takayama M: Effectiveness if isotope therapy in addition to external beam irradiation therapy for pain control due to bone metastases -case report-. J Kyorin Med Soc 45(3):79-82, 2014.